Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises BofA Merrill Lynch and Credit Suisse in connection with Swedbank’s new share issue
Mandate

Vinge advises BofA Merrill Lynch and Credit Suisse in connection with Swedbank’s new share issue

August 17, 2009

Vinge is acting as Swedish legal advisor to BofA Merrill Lynch and Credit Suisse in connection with Swedbank’s 15 billion rights offering. BofA Merrill Lynch and Credit Suisse have agreed to underwrite 53.4% of the shares to be issued in the rights offering, subject to customary terms and conditions, and will act as Joint Global Co-ordinators and Bookrunners for the rights offering.

Vinge’s team consists of Göran Nyström, Rikard Stenberg, Petter Alberts, Johan Thiman and Fredrik Stjernström.

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025